中西医结合治疗乙肝肝硬化顽固性腹水患者的临床疗效评估

目的：对中西医结合治疗乙肝肝硬化顽固性腹水患者的临床疗效进行评估。方法：资料随机选自2012年9月～2013年9月我院收治的乙肝肝硬化顽固性腹水患者80例，平均分为两组，对照组单纯采用常规的西医治疗，研究组在对照组治疗的基础上加用中医辨证施治，并对两组临床资料进行回顾性分析。结果：经治疗后，研究组总有效率为95．00％，明显高于对照组总有效率77．50％，比较有差异具有统计学意义（P〈0．05）。且在两组患者治疗之前及治疗后的腹围、体重、24h尿量对比中，其24h的尿量、腹围、体重都有较为明显的改善，研究组明显优于对照组。结论：通过中西医结合对乙肝肝硬化顽固性腹水患者进行治疗，其治疗效果较为显著，可以让患者的病情得到有效控制、缓解，提升患者的生活质量，值得在临床中广泛推广应用。

Efficacy evaluation on treatment of Hepatitis B liver cirrhosis with refractory ascites by integrated Chinese and western medicine

Objective： To evaluate the treatment of Hepatitis B liver cirrhosis with refractory ascites by integrated Chinese and western medicine. Methods： 80 cases with Hepatitis B liver cirrhosis refractory ascites were randomly selected from September, 2012 to September, 2013 in our hospital and divided into two groups, patients in the control group only treated with conventional western medicine, while patients in research group were treated with Traditional Chinese Medicine differentiation based on therapy for the control group, the clinical data was retrospectively analyzed. Results： After treatment, the total effective rate of the research group was 95.00%, obviously higher than that of the control group 77.50% with statistically significant difference （P 〈 0.05）. Two groups of patients before treatment and after treatment 6 in the 24 h urine volume, weight, contrast, the 24 h urine, 6 has more obvious improvement, body weight, and the situation of the research team were better than the control group. Conclusion： After the treatment of integrated Chinese and western medicine for hepatitis B cirrhosis with refractory ascites, the treatment effect is significant. It can make the patient get effective control and improve the quality of life which is worthy of promotion.